Search research articles
Contact Us
Filters
Showing results (551-560 of 580) with videos related to
Page
of 58
Sort By:
Nature Communications
|
March 24, 2026
LysG-driven transcriptional network rewiring underlies lineage-specific phenotypes in Mycobacterium tuberculosis
Amir Banaei-Esfahani, Sonia Borrell, Andrej Trauner, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Transcript-Capture sequencing enriches mRNA of <i>Mycobacterium tuberculosis</i> from host samples
Eleanor I Lamont, Richard M Jones, Jessica Assadi, et al.
Plos Pathogens
|
January 5, 2011
Hypoxia induces an immunodominant target of tuberculosis specific T cells absent from common BCG vaccines
Hannah Priyadarshini Gideon, Katalin Andrea Wilkinson, Tige R Rustad, et al.
Journal of Intellectual Disability Research : JIDR
|
February 3, 2026
Outcomes of an Exercise Intervention in Adults With Down Syndrome and Congenital Heart Disease: A Secondary Analysis
Julianne G Clina, Brian C Helsel, David A White, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
June 16, 2025
The promotion of physical activity for use in Alzheimer's disease prevention trials in adults with Down syndrome: Results from a 12-month randomized trial
Lauren T Ptomey, Brian C Helsel, Richard A Washburn, et al.
Medicine and Science in Sports and Exercise
|
March 3, 2026
Effectiveness of a Remote Physical Activity Intervention in Individuals with Alzheimer's Disease and their Caregivers: Results from a Randomized Trial
Lauren T Ptomey, Brian C Helsel, Robert N Montgomery, et al.
Contemporary Clinical Trials Communications
|
July 10, 2020
The promotion of physical activity for the prevention of Alzheimer's disease in adults with Down Syndrome: Rationale and design for a 12 Month randomized trial
Lauren T Ptomey, Amanda N Szabo-Reed, Laura E Martin, et al.
Chemistry & Biology
|
June 24, 2014
Folate pathway disruption leads to critical disruption of methionine derivatives in Mycobacterium tuberculosis
Molly R Nixon, Kurt W Saionz, Mi-Sun Koo, et al.
Nature
|
July 6, 2000
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
C K Stover, P Warrener, D R VanDevanter, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 7, 2019
Phase variation in <i>Mycobacterium tuberculosis glpK</i> produces transiently heritable drug tolerance
Hassan Safi, Pooja Gopal, Subramanya Lingaraju, et al.
Page
of 58
Search research articles
Search
Showing results (551-560 of 580) with videos related to
Sort By:
Page
of 58
Nature Communications
|
March 24, 2026
LysG-driven transcriptional network rewiring underlies lineage-specific phenotypes in Mycobacterium tuberculosis
Amir Banaei-Esfahani, Sonia Borrell, Andrej Trauner, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Transcript-Capture sequencing enriches mRNA of <i>Mycobacterium tuberculosis</i> from host samples
Eleanor I Lamont, Richard M Jones, Jessica Assadi, et al.
Plos Pathogens
|
January 5, 2011
Hypoxia induces an immunodominant target of tuberculosis specific T cells absent from common BCG vaccines
Hannah Priyadarshini Gideon, Katalin Andrea Wilkinson, Tige R Rustad, et al.
Journal of Intellectual Disability Research : JIDR
|
February 3, 2026
Outcomes of an Exercise Intervention in Adults With Down Syndrome and Congenital Heart Disease: A Secondary Analysis
Julianne G Clina, Brian C Helsel, David A White, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
June 16, 2025
The promotion of physical activity for use in Alzheimer's disease prevention trials in adults with Down syndrome: Results from a 12-month randomized trial
Lauren T Ptomey, Brian C Helsel, Richard A Washburn, et al.
Medicine and Science in Sports and Exercise
|
March 3, 2026
Effectiveness of a Remote Physical Activity Intervention in Individuals with Alzheimer's Disease and their Caregivers: Results from a Randomized Trial
Lauren T Ptomey, Brian C Helsel, Robert N Montgomery, et al.
Contemporary Clinical Trials Communications
|
July 10, 2020
The promotion of physical activity for the prevention of Alzheimer's disease in adults with Down Syndrome: Rationale and design for a 12 Month randomized trial
Lauren T Ptomey, Amanda N Szabo-Reed, Laura E Martin, et al.
Chemistry & Biology
|
June 24, 2014
Folate pathway disruption leads to critical disruption of methionine derivatives in Mycobacterium tuberculosis
Molly R Nixon, Kurt W Saionz, Mi-Sun Koo, et al.
Nature
|
July 6, 2000
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
C K Stover, P Warrener, D R VanDevanter, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 7, 2019
Phase variation in <i>Mycobacterium tuberculosis glpK</i> produces transiently heritable drug tolerance
Hassan Safi, Pooja Gopal, Subramanya Lingaraju, et al.
Page
of 58